India’s First Robotic Nipple Sparing Mastectomy With Tiloop Breast Implant Reconstruction

Mr. Dinesh Madhavan, President of Group Oncology and International at Apollo Hospitals Enterprise Ltd (AHEL), Dr. Jayanti Thumsi, Lead Surgeon and Robotic Breast Surgeon at Apollo Cancer Centre, Bangalore, and Dr. Manish Mattoo, CEO – Karnataka & Central Region, AHEL, speaking to the media about the groundbreaking robotic breast surgery procedure.

Chennai, January 17th, 2025: Cancer remains the illness most feared across the globe. To combat these ongoing challenges, cancer diagnostics techniques and technology advancements are helping early detection rates, improving life expectancy, and bringing us closer to cancer care.

In this ongoing fight against cancer, treatments are being revamped by adopting modern technologies that have moved cancer care forward by leaps and bounds and enhancing patients’ quality of life. Among these advancements, Robotic Nipple Sparing Mastectomy (RNSM) combined with TiLoop implant reconstruction stands out as a groundbreaking development in breast surgery.

Apollo Cancer Centre (ACC), Bengaluru, successfully conducted India’s first Robotic Nipple Sparing Mastectomy – with Titanised Polypropylene (TPP) Mesh for breast implant reconstruction on a 37-year-old Latha who was diagnosed with right breast cancer in April 2024. The size of her lump was 3 cms x 2.5 cms in size with Lymph nodes in the axilla enlarged.

The expert team lead by Dr. Jayanti Thumsi, Lead & Robotic Breast Surgeon, Apollo Cancer Centre, Bangalore, gave her chemotherapy (NACT) x 16 cycles. She is BRCA negative.